从板块来看，东京证券交易所33个行业板块多数上涨，房地产业、陆地运输业、建筑业等板块涨幅 靠前，有色金属、机械、电气产品等板块下跌。 【纠错】 【责任编辑:焦鹏】 新华社东京11月21日电（记者刘春燕）日本东京股市两大股指21日下跌。日经225种股票平均价格 指数收盘大跌2.40%，东京证券交易所股票价格指数微跌0.06%。 受隔夜纽约股市三大股指全面下跌、纳斯达克股指重挫超2%拖累，东京股市两大股指21日跳空低 开。日经股指低开570多点，其后继续大跌，全天低位徘徊，午盘时段一度下跌1300多点。当天，东京 电子收盘下跌7%，软银集团下跌10.9%，爱德万测试跌幅超过12%。 至收盘时，日经股指下跌1198.06点，收于48625.88点；东证股指下跌1.84点，收于3297.73点。 ...

Core Viewpoint - The company, Dongfang Zhongke, focuses its R&D investments primarily on advanced testing technologies and services, as well as digital security and intelligent applications [2] Group 1 - The company's R&D efforts are concentrated in two main business segments: advanced testing technology and digital security [2] - The company responded to investor inquiries on November 20, indicating its strategic focus areas [2]

Core Viewpoint - The company has not established a robotics division as of now and is currently focused on its main business development while closely monitoring trends in cutting-edge technologies, including robotics [1] Company Summary - The company, 博科测试 (Boke Testing), has responded to investor inquiries indicating that it has not set up a robotics division [1] - The current focus remains on the development of its core business [1] - The company is attentive to advancements in frontier technologies, particularly in the robotics sector [1] Industry Summary - The industry is witnessing a growing interest in robotics and other advanced technologies, which the company is monitoring [1]

Group 1 - The core viewpoint of the article is that 博科测试 (301598.SZ) has not yet established a robotics division and is currently focused on its main business while closely monitoring advancements in cutting-edge technologies, including robotics [1] Group 2 - The company is actively engaged in the development of its primary business [1] - 博科测试 is paying attention to trends in advanced technologies, indicating a potential interest in future investments in robotics [1]

Group 1 - Company announced the progress of share repurchase, having repurchased approximately 21,800 shares, accounting for 0.03% of the total share capital of approximately 64.4 million shares, with a total expenditure of about 830,000 RMB [1] - The highest repurchase price was 39.02 RMB per share, while the lowest was 37 RMB per share [1] - For the year 2024, the revenue composition of the company is 99.13% from power system testing and 0.87% from other businesses [1] Group 2 - The current market capitalization of the company is 2.6 billion RMB [2]

Group 1 - The company announced the approval of proposals for issuing H-shares and listing on the Hong Kong Stock Exchange to enhance international brand recognition and competitiveness [2] - The company aims to consider the interests of existing shareholders and market conditions when selecting the timing for the H-share issuance [2] - The company reported a revenue of 386 million yuan for the first three quarters of 2025, representing a year-on-year growth of 30.29%, driven by the ramp-up of new energy vehicle powertrain testing services and intelligent driving business [2] Group 2 - The company recorded a net loss attributable to shareholders of 45.95 million yuan and a non-recurring net loss of 29.28 million yuan, primarily due to gradual capacity release and increased fixed costs amid intense market competition [2] - The company faced challenges with cash flow, reporting a net cash flow from operating activities of -30.43 million yuan due to poor collection of sales receivables and high payments to suppliers and taxes [2]

Group 1 - The core viewpoint of the article highlights the financial performance of Boke Testing in Q3 2025, showing a revenue increase and net profit growth despite a decline in basic earnings per share [1] Group 2 - Boke Testing reported a revenue of approximately 362 million yuan for the first three quarters of 2025, representing a year-on-year increase of 12.32% [1] - The net profit attributable to shareholders was approximately 77.98 million yuan, reflecting a year-on-year increase of 19.6% [1] - The basic earnings per share decreased by 10.3% to 1.324 yuan [1] Group 3 - As of the report, Boke Testing's market capitalization stands at 4 billion yuan [2] - The article also discusses the broader context of the Chinese innovative drug market, noting that overseas licensing has generated 80 billion USD this year [2]

Group 1 - The core point of the article is that 博科测试 (Boke Testing) has stated on its investor interaction platform that the company currently has no chip testing cases [1] Group 2 - The company is involved in the testing industry but is not currently engaged in chip testing [1] - The announcement may indicate a focus on other testing areas or a lack of demand for chip testing services at this time [1] - This information could be relevant for investors assessing the company's market position and future opportunities [1]

Core Viewpoint - The company, Boke Testing (301598), has developed advanced seismic simulation testing systems for various nuclear power users, which will also be applied in controlled nuclear fusion power plants [1] Group 1 - The company provides world-class seismic simulation testing systems for nuclear power facilities [1] - These systems support users in the research, design, and construction of various nuclear facilities [1] - The company is committed to monitoring the development and application of cutting-edge technologies in the nuclear field [1]

Core Viewpoint - The company has developed advanced seismic simulation testing systems for various nuclear power users, which will support the research, design, and construction of nuclear facilities, including controlled nuclear fusion power plants [1] Group 1 - The company has provided seismic simulation testing systems that meet world-class standards [1] - These systems are utilized for research, design, and construction of various nuclear facilities [1] - The company will continue to focus on the development and application of cutting-edge technologies in the nuclear field [1]